Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1988 | 12-1987 | 12-1986 | |
| Sales | 8,558,000 | 7,558,000 | 4,835,900 |
| Cost of Goods | 2,484,000 | 2,302,000 | 1,515,200 |
| Gross Profit | 6,074,000 | 5,256,000 | 3,320,700 |
| Operating Expenses | 4,304,000 | 3,789,000 | 2,434,600 |
| Operating Income | 1,770,000 | 1,467,000 | 886,300 |
| Other Income | 119,000 | 161,000 | 44,100 |
| Pre-tax Income | 1,889,000 | 1,628,000 | 930,400 |
| Income Tax | 635,000 | 560,000 | 340,900 |
| Net Income Continuous | 1,254,000 | 1,068,000 | 589,500 |
| Net Income | $1,254,000 | $1,068,000 | $589,500 |
| EPS Basic Total Ops | 1.09 | 0.93 | 0.52 |
| EPS Basic Continuous Ops | 0.60 | 0.50 | 0.52 |
| EPS Diluted Total Ops | 0.60 | 0.50 | N/A |
| EPS Diluted Continuous Ops | 0.60 | 0.50 | N/A |
| EBITDA(a) | $1,955,000 | $1,628,000 | $886,300 |